View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Modality Solutions
22 January 2020

Modality Solutions Announces 2019 Year-End Milestones

Modality Solutions specialises in integrating cold chain operations, developing transport validation strategies, supporting global regulatory applications, and executing global clinical trial operations.

Milestone highlights include recognition by both Inc. 5000 and the Houston Business Journal as a fastest growing company, and ISO 9001:2015 certification with the scope of the accreditation covering consulting, design and engineering services and testing for supply chain logistics related to transport-sensitive drug products.

Modality Solutions also received the distinction of being one of the “Best Entrepreneurial Companies in America” by Entrepreneur magazine on its 2019 Entrepreneur 360™ List. “Our annual evaluation is a 360-degree analysis of top privately-held companies representing and serving a variety of industries,” explains Lisa Murray, Chief Insights Officer of Entrepreneur Media, Inc. “These businesses are real-world case studies for any entrepreneur who seeks to master the four pillars that can greatly impact the longevity and growth of their businesses. With the Entrepreneur 360, success is measured by achieving balance throughout the entire organization, predicated by revenue.”

Co-founder and President, Gary Hutchinson, was accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives. Hutchinson was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honours.

Modality Solutions achieved their first-ever ranking on Inc. Magazine’s annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. It reported three-year revenue growth of 120 per cent and ranked No. 47 in the Inc. industry category of top engineering companies. Also, in its first appearance on the Houston Business Journal’s Fast 100 list, the company ranked No. 91 with reported two-year revenue growth of 56 per cent.

“2019 was a stellar year for us, with ISO 9001:2015 certification, recognition by Inc. and Entrepreneur magazines, participation in the Forbes Tech Council, and continuing to partner with our clients to validate safe and effective cold chains,” said President Hutchinson. “As we continue our mission into the next decade, our vision for the future is to continue to expand with our team of experienced engineers our ongoing role to promote safe, effective, and validated cold chain for a whole range of therapies.”

The company’s commitment to growth included promoting from within Andrew Larrigan and Robert Battista to Senior Consulting Engineers and adding Rachel Sawyer as Consulting Engineer. In her new position, Sawyer works with other dedicated project engineers to ensure proper design and use of cold chain systems.

The biopharmaceutical industry benefited from Modality Solutions’ first live webinar on Sept. 19. Principals Gary Hutchinson and Daniel Littlefield covered a step-by-step cold chain validation process to help pharmaceutical companies meet and exceed increasingly stringent regulatory expectations, including monoclonal antibodies, antibody-drug conjugates, and cell therapies.

To wrap up its year of achievements, Modality Solutions was a Silver Sponsor and cold chain validation workshop presenter at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, 2019, at the Hilton La Jolla Torrey Pines in San Diego, California. Hutchinson and Littlefield presented “Cold Chain Validation Best Practices Including Immunotherapy”

To learn more about Modality Solutions, please fill out the enquiry form attached to this page.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics (www.immunomedics.com) is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology